Sebastián Bernales

MediVation, Inc. /MA/ provides fully automated web-based communication systems to securely educate and communicate with patients online. The company is based in Needham, MA. MediVation, Inc. /MA was acquired by McKesson Corp. on July 05, 2000.

Humboldt Capital LLC (Humboldt Capital) is a venture capital firm founded in 2020. The firm is headquartered in New York.

Miroculus, Inc. operates as a biotechnology company specializing in microRNA-based diagnostics. It offers a non-invasive microRNA detection platform for molecular data gathering, analysis, and interpretation applications. The company was founded by Alejandro Tocigl Domeyko, Jorge Soto and Fay Christodoulou and is headquartered in San Francisco, CA.

Phage Technologies SA develops bacteriophage treatments for controlling bacteria in breeding processes in the poultry, livestock, and aquaculture industry. The company is based in Macul, Chile. The Chilean company aims to reduce the use of antibiotics for disease control. The CEO of the company is Hans Pieringer.

Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina.

viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation.